In a recent interview with Impact Loop, Stratipath co-founder Johan Hartman shared exciting insights into Stratipath’s role in transforming cancer care:

“We have the first product in this field approved for hospital use. But AI is advancing rapidly, so there will be competition, which is great. The market is large, so there’s room for more players.”